XEC.* appears to have taken over dominance from the DeFLuQE variants in mid-November.
XEC.* grew to around 40%.
#COVID19 #Australia #DeFLuQE #XEC
🧵
XEC.* appears to have taken over dominance from the DeFLuQE variants in mid-November.
XEC.* grew to around 40%.
#COVID19 #Australia #DeFLuQE #XEC
🧵
Here are the leading contenders: LP.8.1, MC.10.2, MV.1, and XEC.4.
More details:
aus.social/@mike_honey_...
Here are the leading contenders: LP.8.1, MC.10.2, MV.1, and XEC.4.
More details:
aus.social/@mike_honey_...
The leading contenders at this point are LP.8.1 and XEC.4.
They are shown here using a log scale, to compare their growth rates vs OG XEC.
#COVID19 #XEC #LP_8_1
🧵
Top lineages -#30DayTrends #G30
XEC (26.5%)
KP.3.1.1 (7.2%)
LP.8.1.1 (5.6%)
LP.8.1 (4.7%)
MC.1 (4.5%)
XEC.4 (4.5%)
MC.10.1 (4%)
XEC.2 (3.4%)
XEC.8 (2.9%)
XEC.9 (1.9%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (26.5%)
KP.3.1.1 (7.2%)
LP.8.1.1 (5.6%)
LP.8.1 (4.7%)
MC.1 (4.5%)
XEC.4 (4.5%)
MC.10.1 (4%)
XEC.2 (3.4%)
XEC.8 (2.9%)
XEC.9 (1.9%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (24.4%)
LP.8.1.1 (6.8%)
LP.8.1 (6.5%)
KP.3.1.1 (5.1%)
XEC.4 (4.5%)
MC.10.1 (4.2%)
MC.1 (3.7%)
XEC.2 (3.6%)
XEC.8 (3%)
XEC.9 (1.6%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (24.4%)
LP.8.1.1 (6.8%)
LP.8.1 (6.5%)
KP.3.1.1 (5.1%)
XEC.4 (4.5%)
MC.10.1 (4.2%)
MC.1 (3.7%)
XEC.2 (3.6%)
XEC.8 (3%)
XEC.9 (1.6%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (23.6%)
LP.8.1.1 (8.2%)
LP.8.1 (7.4%)
KP.3.1.1 (5%)
MC.10.1 (4.6%)
XEC.4 (4.2%)
XEC.2 (4.1%)
MC.1 (3.2%)
XEC.8 (2.6%)
XEC.9 (2%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (23.6%)
LP.8.1.1 (8.2%)
LP.8.1 (7.4%)
KP.3.1.1 (5%)
MC.10.1 (4.6%)
XEC.4 (4.2%)
XEC.2 (4.1%)
MC.1 (3.2%)
XEC.8 (2.6%)
XEC.9 (2%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (27.2%)
KP.3.1.1 (8.9%)
MC.1 (4.9%)
LP.8.1.1 (4.3%)
MC.10.1 (4.3%)
XEC.2 (4%)
LP.8.1 (3.9%)
XEC.4 (3.7%)
XEC.8 (1.9%)
XEC.9 (1.8%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (27.2%)
KP.3.1.1 (8.9%)
MC.1 (4.9%)
LP.8.1.1 (4.3%)
MC.10.1 (4.3%)
XEC.2 (4%)
LP.8.1 (3.9%)
XEC.4 (3.7%)
XEC.8 (1.9%)
XEC.9 (1.8%)
Global Tracker: public.tableau.com/app/profile/...
1/n
You down with KP.3?
You down with KP.3?
Top lineages -#30DayTrends #G30
LP.8.1.1 (22%)
XEC (15.3%)
LP.8.1 (12%)
XEC.4 (6%)
MC.10.1 (4.2%)
LF.7 (3.4%)
XEC.2 (2.8%)
LF.7.2.1 (2.6%)
XEC.8 (1.8%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
LP.8.1.1 (22%)
XEC (15.3%)
LP.8.1 (12%)
XEC.4 (6%)
MC.10.1 (4.2%)
LF.7 (3.4%)
XEC.2 (2.8%)
LF.7.2.1 (2.6%)
XEC.8 (1.8%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
LP.8.1.1 (19.5%)
XEC (15.6%)
LP.8.1 (12.5%)
XEC.4 (5.7%)
MC.10.1 (4.3%)
LF.7 (3.9%)
XEC.2 (2.6%)
LF.7.2.1 (2.3%)
XEC.8 (1.8%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
LP.8.1.1 (19.5%)
XEC (15.6%)
LP.8.1 (12.5%)
XEC.4 (5.7%)
MC.10.1 (4.3%)
LF.7 (3.9%)
XEC.2 (2.6%)
LF.7.2.1 (2.3%)
XEC.8 (1.8%)
Global Tracker: public.tableau.com/app/profile/...
1/n
The leading contender at this point is LP.8.1. MC.10.2 and NP.1 seem to have fallen by the wayside.
#COVID19 #XEC
🧵
The growth of DeFLuQE variants appears to have ended.
XEC.* grew to around 35%.
#COVID19 #Australia #DeFLuQE #XEC @auscovid19@a.gup.pe
🧵
The growth of DeFLuQE variants appears to have ended.
XEC.* grew to around 35%.
#COVID19 #Australia #DeFLuQE #XEC @auscovid19@a.gup.pe
🧵
Top lineages -#30DayTrends #G30
XEC (22.5%)
LP.8.1.1 (9.9%)
LP.8.1 (8.4%)
MC.10.1 (4.6%)
KP.3.1.1 (4.4%)
XEC.2 (4.3%)
XEC.4 (3.4%)
MC.1 (2.5%)
XEC.8 (2.3%)
LF.7 (2%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (22.5%)
LP.8.1.1 (9.9%)
LP.8.1 (8.4%)
MC.10.1 (4.6%)
KP.3.1.1 (4.4%)
XEC.2 (4.3%)
XEC.4 (3.4%)
MC.1 (2.5%)
XEC.8 (2.3%)
LF.7 (2%)
Global Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (30.7%)
KP.3.1.1 (18.6%)
LP.8.1 (5.6%)👀
MC.1 (4.3%)
XEC.2 (4.2%)
MC.10.1 (3%)
XEC.4 (2.3%)
XEK (2.3%)
NP.1 (1.5%)
XEL (1.5%)
Global Trends Tracker: public.tableau.com/app/profile/...
1/n
Top lineages -#30DayTrends #G30
XEC (30.7%)
KP.3.1.1 (18.6%)
LP.8.1 (5.6%)👀
MC.1 (4.3%)
XEC.2 (4.2%)
MC.10.1 (3%)
XEC.4 (2.3%)
XEK (2.3%)
NP.1 (1.5%)
XEL (1.5%)
Global Trends Tracker: public.tableau.com/app/profile/...
1/n
XEC.* variants took over dominance from DeFLuQE variants during December, but they are already under pressure.
The LP.8.1.* group of variants have emerged as a challenger, rising steadily to around 10%.
#COVID19 #Global #XEC #LP_8_1
🧵